Tina Bhutani-Jacques, MD

Photo of Tina Bhutani-Jacques, MD
Title(s)Associate Professor, Dermatology
SchoolSchool of Medicine
Address513 Parnassus Avenue HSW, #1201H
San Francisco CA 94143
ORCID ORCID Icon0000-0001-8187-1024 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    I am a dermatologist and clinical researcher in the Department of Dermatology at UCSF. I serve as co-director of the Psoriasis and Skin Treatment Center, a world-renowned clinic dedicated to the care of patients with psoriasis. My clinical expertise includes the treatment of complex, treatment resistant cases of inflammatory skin diseases using unique combinations of topical agents, systemic treatments, biologics, and phototherapy. I also direct the Dermatology Clinical Research Unit where I utilize my advanced training in clinical research methods to oversee numerous sponsored and investigator-initiated clinical studies and supervise a research team consisting of a post-doctoral research fellow, 3 clinical research coordinators, and 3 medical students. I am currently the PI for 6 clinical trials developing new therapeutics or diagnostics for psoriasis, atopic dermatitis, and alopecia areata.

    My research thus far has focused on assessing and improving quality of life and mental health in patients with psoriasis by treating their skin disease effectively. I now would like to expand upon this focus and look for methods to decrease the stress burden of psoriasis and improve patient well-being in the hopes of improving quality of life in a new and unique way. Nutrition, exercise, sleep, social connectedness, and mindfulness are the five pillars known to increase overall wellness in both healthy and diseased patients. Over my career, I hope to look further into each of these aspects and their importance in inflammatory skin disease, starting with a research program focusing on sleep in psoriasis and its impact on disease severity, mental health and cardiometabolic comorbidities.

    Collapse Biography 
    Collapse education and training
    University of California, San Diego, La Jolla, CABS06/2004Animal Physiology and Neuroscience
    University of Southern California, Keck School of Medicine, Los Angeles, CAMD06/2008Medicine
    university of California, San Diego, San Diego, CA06/2009Internal Medicine Internship
    University of California, San Francisco, San Francisco, CA06/2012Psoriasis, Phototherapy, and Clinical Trials Research Fellowship
    University of California, San Francisco, San Francisco, CA06/2015Dermatology Residency
    University of California, San Francisco, San Francisco, CAMAS6/2017Masters in Clinical Research
    Collapse awards and honors
    National Psoriasis Foundation2010  - 2011Medical Dermatology Fellowship Research Grant
    National Psoriasis Foundation2017  - 2018Discovery Grant
    Dermatology Foundation2021Medical Dermatology Career Development Award
    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis2021Pilot Research Grant
    National Psoriasis Foundation2021More than Skin Deep: Mental Health Grant

    Collapse Research 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Patient Experience and Preferences for Treatments in Atopic Dermatitis. Dermatol Ther (Heidelb). 2026 Sep 08. Dasilva DR, Burshtein J, Weinberg J, Koo J, Bhutani-Jacques T, Hurton LV, Farberg AS, Friedman A, Lio PA. PMID: 42709335.
      View in: PubMed   Mentions:
    2. GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees. J Rheumatol. 2026 09 01; 53(Suppl 2):28-32. Spangenberg A, Bhutani T, Ferguson LD, Makos A, Nakamura A, Piccinelli A, Adami G, Amarasena R, Gisondi P, Kehoe O, Kuiper JH, Rossini M, Sattar N, Siebert S, de Vlam K, Chandran V, Liao W. PMID: 42140635.
      View in: PubMed   Mentions:    Fields:    
    3. Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities. Dermatol Ther (Heidelb). 2026 Sep; 16(9):4433-4458. Barbosa V, Bhutani-Jacques T, Callender VD, Bacci ED, Pierce E, Mitchell B, Correll JR, Huang N. PMID: 42458187; PMCID: PMC13558543.
      View in: PubMed   Mentions:
    4. Clinical and genetic characterization of genital and inverse psoriasis as a distinct psoriasis endotype. J Invest Dermatol. 2026 Jul 11. Chen MK, Haran K, Diaz MJ, Orcales F, Kumar S, Smith P, Johnson C, Kranyak A, Fang X, Bhutani T, Duffin KC, Feng BJ, Liao W. PMID: 42435985.
      View in: PubMed   Mentions:    Fields:    
    5. Topical Prescription Therapy for Psoriasis: An Expert Position Paper on Limitations of Published Guidelines and Treatment Selection With Updated Recommendations. J Clin Aesthet Dermatol. 2026 Jun; 19(6):15-21. Burshtein J, Zakria D, Bhutani T, Bunick CG, Costner M, DiRuggiero D, Friedman A, Golant AK, Song EJ, Gold LS, Young M, Del Rosso JQ. PMID: 42482862; PMCID: PMC13387667.
      View in: PubMed   Mentions:
    6. Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease. J Dermatol. 2026 Jul; 53(7):1026-1031. Puig L, Tsai TF, Soriano ER, Bhutani T, Miller M, Kollmeier AP, Li S, Li H, Ofori S, Pawlikowski J, Adamson E, Gooderham M, Londoño Garcia A, Lebwohl M, Nash P. PMID: 42226468; PMCID: PMC13341047.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial. Dermatol Ther (Heidelb). 2026 Jun; 16(6):3215-3234. Elbuluk N, Armstrong AW, Vender R, Bhutani T, Green L, Ferris LK, Laquer V, Moore A, Weisman J, Zhang W, Winkelman W, Gooderham MJ. PMID: 42143206; PMCID: PMC13237397.
      View in: PubMed   Mentions:
    8. Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium. Am J Clin Dermatol. 2026 Jul; 27(4):803-818. Payette M, Bhutani T, Young M, Boreham M, Whitney L, Koo J, Fried R, Johnson S, Admani S, Jakus J, Mayo T, Zampella JG, Seal MS, Hanna D, Bohnert K, Cather J. PMID: 42126816; PMCID: PMC13375702.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Determinants of Quality of Life and Mental Health in Kenyan Psoriasis Patients: A Cross-Sectional Analysis from the Kenyan Psoriasis Registry. J Psoriasis Psoriatic Arthritis. 2026 Mar 09; 24755303261433913. Chen MK, Biwott P, Muraguri I, Marquez-Grap G, Baldonado GC, Smith P, Maurer T, Bhutani T, Kiprono S, Liao W. PMID: 41816259; PMCID: PMC12971513.
      View in: PubMed   Mentions:
    10. The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. Dermatol Ther (Heidelb). 2026 Apr; 16(4):2031-2045. Alexis A, McMichael A, Vashi N, Bhutani T, Yeung J, Alkousakis T, Rowland K, Choi O, Ma T, Chan D, Lester J, Rodriguez AO, Yadav G, Kindred C, Grimes P, Taylor SC, Desai SR. PMID: 41770445; PMCID: PMC13047027.
      View in: PubMed   Mentions:
    11. The Impact of Dupilumab on Psychological Wellbeing in Moderate-to-Severe Atopic Dermatitis Patients: A Phase IV Clinical Trial. J Clin Aesthet Dermatol. 2026 Mar; 19(3):15-19. Johnson CE, Elhage KG, Spencer RK, Jin JQ, Yeroushalmi S, Davis MS, Hakimi M, Liao W, Bhutani T. PMID: 42027418; PMCID: PMC13102155.
      View in: PubMed   Mentions:
    12. Real-World Evidence of Brodalumab Effectiveness for the Treatment of Psoriasis. J Drugs Dermatol. 2026 Feb 01; 25(2):126-131. Lebwohl MG, Bhutani T, Soung J, Lain E, Jacobson A. PMID: 41642147.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice. Am J Clin Dermatol. 2026 Jan; 27(1):9-16. Leung A, Kranyak A, Marquez-Grap G, Bhutani T. PMID: 41369865.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. FDA Boxed Warnings: Should Package Inserts Include Levels of Evidence? J Drugs Dermatol. 2025 Dec 01; 24(12):e67-e69. Leung A, Bhutani T, Brownstone N, Koo J. PMID: 41329153.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative. Nat Rev Rheumatol. 2026 Feb; 22(2):132-144. Proft F, Ribeiro AL, Singla S, Chandran V, Liao W, Lindsay C, Soriano ER, Bhutani T, Deodhar A, de Vlam K, Eder L, Kishimoto M, Leung YY, Lubrano E, McGonagle D, Poddubnyy D, Savage L, Van den Bosch F, Mease P. PMID: 41310208.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Real-world Evidence of Brodalumab Safety for the Treatment of Psoriasis. J Psoriasis Psoriatic Arthritis. 2025 Oct 24; 24755303251382878. Lebwohl M, Song EJ, Bhutani T, Green L, Jacobson A. PMID: 41142137; PMCID: PMC12552225.
      View in: PubMed   Mentions:
    17. The Environmental Impact of Biologic Therapy. Dermatol Clin. 2026 Jan; 44(1):137-143. Leung A, Marquez-Grap G, Bhutani T. PMID: 41207770.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. Clinical Observation: Patient with Difficult-to-Treat Psoriasis Experiences Skin Clearing After Removal of Silicone Breast Implants. Skin (Milwood). 2025 May; 9(3):2395-2397. Kranyak A, Johnson C, Haran K, Smith P, Liao W, Bhutani T. PMID: 41306416; PMCID: PMC12646026.
      View in: PubMed   Mentions:
    19. Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025 Sep 01; 161(9):901-911. Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR, VISIBLE Trial Investigators. PMID: 40560559; PMCID: PMC12199184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    20. Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation. JAMA Dermatol. 2025 Aug 01; 161(8):863-869. Armstrong AW, Gondo GC, Merola JF, Roberts AM, Pérez-Chada LM, Balak DMW, Eakin GS, Read C, Le ST, Gutierrez Y, Bhutani T, Blauvelt A, Duffin KC, Fakharzadeh S, Feldman SR, Gelfand JM, Gladman DD, Glick B, Green LJ, Han G, Hawkes JE, Hwang ST, Johnsen N, Kalb RE, Kircik L, Langley RG, Lebwohl MG, Lewitt GM, Maverakis E, Prussick R, Reddy SM, Rosen CF, Scher JU, Siegel EL, Wallace EB, Weinberg JM, Yamauchi PS, Yosipovitch G, Liao W, Remission Workgroup of the National Psoriasis Foundation. PMID: 40531503.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials. Dermatol Ther (Heidelb). 2025 Sep; 15(9):2667-2682. Alexis AF, Kircik L, Chovatiya R, Rice ZP, Soong W, Bhutani T, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM, Armstrong AW. PMID: 40696240; PMCID: PMC12354664.
      View in: PubMed   Mentions: 1  
    22. Evaluation of the environmental impact of medication packaging in dermatology. J Dermatolog Treat. 2025 Dec; 36(1):2528719. Marquez-Grap G, Leung A, Smith P, Bhutani T. PMID: 40677124.
      View in: PubMed   Mentions:    Fields:    
    23. The Impact of Psoriasis on Sleep Quality: Examining the Relationship Between Psoriasis, Sleep, and Mental Health. Dermatol Ther (Heidelb). 2025 Aug; 15(8):2247-2254. Leung A, Haran K, Marquez-Grap G, Chang K, Johnson CE, Kranyak A, Bhutani T, Liao W. PMID: 40553387; PMCID: PMC12256367.
      View in: PubMed   Mentions: 1  
    24. Alopecia areata severity and patient-reported intimacy: A cross-sectional survey study. JAAD Int. 2025 Oct; 22:20-22. Bao A, Jin J, Smith C, Hakimi M, Mehta KM, Bhutani T, Fu J. PMID: 40688434; PMCID: PMC12271424.
      View in: PubMed   Mentions:
    25. Patient-reported Impact of Menopause and Hormone Replacement Therapy on Psoriasis. Acta Derm Venereol. 2025 Apr 09; 105:adv42843. Chung BY, Johnson C, Park JS, Haran K, Smith P, Kranyak A, Bhutani T, Liao W. PMID: 40205797; PMCID: PMC12001492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Global Delphi consensus on treatment goals for generalized pustular psoriasis. Br J Dermatol. 2025 03 18; 192(4):706-716. Barker JN, Casanova E, Choon SE, Foley P, Fujita H, Gonzalez C, Gooderham M, Marrakchi S, Puig L, Romiti R, Thaçi D, Zheng M, Strober B, Partnering for Innovation and Excellence in Rare Skin Diseases (PIONEERS®) Working Group and the DEL. PMID: 39844356.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement. JAMA Dermatol. 2025 03 01; 161(3):256-264. Alexis A, McMichael A, Vashi N, Bhutani T, Rodriguez AO, Yeung J, Choi O, Chan D, Alkousakis T, Bronner DN, Park-Wyllie L, Gao LL, Grimes P, Shahriari M, Yadav G, Kindred C, Taylor SC, Desai SR. PMID: 39661358; PMCID: PMC11923717.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Increased sodium consumption is associated with psoriasis: A population-based cohort study. J Eur Acad Dermatol Venereol. 2025 Sep; 39(9):1622-1630. Chattopadhyay A, Ye M, Chiang B, Halezeroglu Y, Van Blarigan EL, Liao W, Bhutani T, Abuabara K. PMID: 39876665.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. A case of a patient with erythema annulare centrifugum found to have aggressive fibromatosis. JAAD Case Rep. 2025 Jan; 55:48-50. Haran K, Kranyak A, Johnson CE, Smith PL, Hunt S, Liao W, Bhutani T. PMID: 39802945; PMCID: PMC11719283.
      View in: PubMed   Mentions:
    30. Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis. J Clin Aesthet Dermatol. 2024 Oct; 17(10):63-67. Vasquez JG, Heim JM, Bhutani T, Koo J, Mathew J, Ferro T, Bhatia N. PMID: 39445319; PMCID: PMC11495160.
      View in: PubMed   Mentions: 1  
    31. Tackling Multiple Biologic Failure in Psoriasis: Research and Advocacy Perspectives. J Psoriasis Psoriatic Arthritis. 2024 Sep 30; 24755303241288536. Haran K, Gondo G, Smith P, Johnson C, Kranyak A, Bhutani T, Liao W. PMID: 39544334; PMCID: PMC11559563.
      View in: PubMed   Mentions:
    32. The association of interleukin-36 staining intensity with histopathologic findings of eosinophil count and spongiosis in patients with psoriasis: A secondary analysis of a retrospective immunohistochemical and chart review pilot study. J Cutan Pathol. 2025 Apr; 52(4):251-253. Zhang WR, Bhutani T, Schulman JM, North JP. PMID: 39215601.
      View in: PubMed   Mentions:    Fields:    
    33. Adapting the Goeckerman Regimen for Psoriasis Treatment in Kenya: A Case Study of Successful Management in a Resource-Limited Setting. Psoriasis (Auckl). 2024; 14:93-100. Smith P, Kranyak A, Johnson CE, Haran K, Muraguri Snr I, Maurer T, Bhutani T, Liao W, Kiprono S. PMID: 39224150; PMCID: PMC11368149.
      View in: PubMed   Mentions: 2  
    34. Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis. Psoriasis (Auckl). 2024; 14:87-92. Haran K, Kranyak A, Johnson CE, Smith P, Farberg AS, Bhutani T, Liao W. PMID: 39132449; PMCID: PMC11314430.
      View in: PubMed   Mentions:
    35. The Impact of At-Home Narrow-Band UVB Phototherapy for Mild-to-Severe Psoriasis: A Retrospective, Multicenter, Observational Study. J Drugs Dermatol. 2024 08 01; 23(8):e169-e170. PMID: 39093655.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Treating Chronic Pruritus: Are We at the Threshold of a Breakthrough? Skin (Milwood). 2024 Jul; 8(4):1711-1713. Smith P, Kranyak A, Johnson CE, Haran K, Liao W, Bhutani T, Koo J. PMID: 39324151; PMCID: PMC11423949.
      View in: PubMed   Mentions: 1  
    37. Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports. Drug Saf. 2024 Oct; 47(10):1039-1049. Mahadevan U, Levy G, Gensler L, Ali M, Lacerda AP, Wegrzyn L, Palac H, Bhutani-Jacques T, Long M, Clowse MEB, Kimball AB, Chambers C, Scialli AR. PMID: 39008024; PMCID: PMC11399166.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    38. Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database. Dermatol Ther (Heidelb). 2024 Aug; 14(8):2277-2283. Smith P, Jin JQ, Spencer RK, Elhage KG, Johnson CE, Haran K, Kranyak A, Davis MS, Hakimi M, Prather AA, Stone KL, Liao W, Bhutani T. PMID: 38940897; PMCID: PMC11333390.
      View in: PubMed   Mentions: 8  
    39. Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey. J Dermatolog Treat. 2024 Dec; 35(1):2366532. Bhutani T, Jayade S, Rege S, Penton H, Patel V, Kalirai S, Wolin D, Boyle K, Seigel L. PMID: 38914422.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Advancing Psoriasis Care through Artificial Intelligence: A Comprehensive Review. Curr Dermatol Rep. 2024 Sep; 13(3):141-147. Smith P, Johnson CE, Haran K, Orcales F, Kranyak A, Bhutani T, Riera-Monroig J, Liao W. PMID: 39301276; PMCID: PMC11412311.
      View in: PubMed   Mentions: 5  
    41. Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'. Br J Dermatol. 2024 03 15; 190(4):596. Johnson C, Smith P, Haran K, Kranyak A, Liao W, Bhutani T. PMID: 38149911.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence. Dermatol Ther (Heidelb). 2024 Feb; 14(2):341-360. Bhutani T, Farberg AS. PMID: 38363460; PMCID: PMC10891013.
      View in: PubMed   Mentions: 8  
    43. A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Sci Immunol. 2024 01 26; 9(91):eadi2848. Wu D, Hailer AA, Wang S, Yuan M, Chan J, El Kurdi A, Rahim M, Kondo A, Han D, Ali H, D'Angio B, Mayer A, Klufas D, Kim E, Shain AH, Choi J, Bhutani T, Simpson G, Grekin RC, Ricardo-Gonzalez R, Purdom E, North JP, Cheng JB, Cho RJ. PMID: 38277466.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    44. The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients. J Psoriasis Psoriatic Arthritis. 2024 Apr; 9(2):69-81. Kranyak A, Haran K, Smith P, Johnson C, Liao W, Bhutani T. PMID: 39156223; PMCID: PMC11329232.
      View in: PubMed   Mentions: 7  
    45. Current practices for pediatric phototherapy: Findings from a cross-sectional study. Pediatr Dermatol. 2024 Jan-Feb; 41(1):66-69. Spencer RK, Bartholomew E, Padniewski J, Bhutani T, Asch S. PMID: 38018915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast]. Clin Cosmet Investig Dermatol. 2023; 16:3333-3339. Hawkes JE, Reisner DV, Bhutani T. PMID: 38021429; PMCID: PMC10663504.
      View in: PubMed   Mentions: 1  
    47. Mendelian Randomization Studies in Atopic Dermatitis: A Systematic Review. J Invest Dermatol. 2024 05; 144(5):1022-1037. Elhage KG, Kranyak A, Jin JQ, Haran K, Spencer RK, Smith PL, Davis MS, Hakimi M, Bhutani T, Liao W. PMID: 37977498.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    48. Optimizing Single T-Cell Transcriptomic Discrimination of Atopic Dermatitis Versus Psoriasis Vulgaris. J Invest Dermatol. 2024 04; 144(4):898-901.e3. Taylor MA, El Kurdi A, Hailer A, Wang S, Yuan M, Mukhopadhyay S, Bhutani T, North JP, Cho RJ, Cheng JB. PMID: 37879399.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    49. Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2903-2909. Spencer RK, Jin JQ, Elhage KG, Davis MS, Hakimi M, Gondo G, Liao W, Bhutani T. PMID: 37798556; PMCID: PMC10613158.
      View in: PubMed   Mentions: 1  
    50. A Pilot Study to Assess the Reliability of Digital Image-Based PASI Scores Across Patient Skin Tones and Provider Training Levels. Dermatol Ther (Heidelb). 2022 Jul; 12(7):1685-1695. Wu D, Lu X, Nakamura M, Sekhon S, Jeon C, Bhutani T, Liao W. PMID: 35727498; PMCID: PMC9276898.
      View in: PubMed   Mentions: 6  
    51. A cross-sectional study of ethnic and racial disparities in pediatric atopic dermatitis clinical trials. J Am Acad Dermatol. 2023 02; 88(2):453-455. Mosca M, Hadeler E, Hong J, Hakimi M, Bhutani T, Liao W. PMID: 35690166.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis. Dermatol Ther (Heidelb). 2022 Jun; 12(6):1289-1302. Menter A, Bhutani T, Ehst B, Elewski B, Jacobson A. PMID: 35672564; PMCID: PMC9209590.
      View in: PubMed   Mentions: 10  
    53. Single Cell Transcriptome and Surface Epitope Analysis of Ankylosing Spondylitis Facilitates Disease Classification by Machine Learning. Front Immunol. 2022; 13:838636. Alber S, Kumar S, Liu J, Huang ZM, Paez D, Hong J, Chang HW, Bhutani T, Gensler LS, Liao W. PMID: 35634297; PMCID: PMC9135966.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    54. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358. Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. PMID: 35439608.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    55. The role of gender, race, and ethnicity in psoriasis patients with COVID-19 infection: A cross-sectional study. Int J Womens Dermatol. 2022 Mar; 8(1):e012. Nguyen C, Shwe S, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Bhutani T. PMID: 35369119; PMCID: PMC8939651.
      View in: PubMed   Mentions:
    56. Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis. Dermatol Ther (Heidelb). 2022 Mar; 12(3):753-760. Gondo G, Hadeler E, Brownstone N, Maverakis E, Merola JF, Armstrong AW, Bhutani T, Bell SJ, Liao W. PMID: 35254634; PMCID: PMC8941001.
      View in: PubMed   Mentions: 3  
    57. Combined Single Cell Transcriptome and Surface Epitope Profiling Identifies Potential Biomarkers of Psoriatic Arthritis and Facilitates Diagnosis via Machine Learning. Front Immunol. 2022; 13:835760. Liu J, Kumar S, Hong J, Huang ZM, Paez D, Castillo M, Calvo M, Chang HW, Cummins DD, Chung M, Yeroushalmi S, Bartholomew E, Hakimi M, Ye CJ, Bhutani T, Matloubian M, Gensler LS, Liao W. PMID: 35309349; PMCID: PMC8924042.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    58. Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):68-72. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Kirby JS, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878495; PMCID: PMC8655660.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    59. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):73-78. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Kirby JS, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878491; PMCID: PMC8655659.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    60. The Role of IL-17 Cytokines in Psoriasis. Immunotargets Ther. 2021; 10:409-418. Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T. PMID: 34853779; PMCID: PMC8627853.
      View in: PubMed   Mentions: 54  
    61. Off-label uses of TNF-a inhibitors and IL-12/23 inhibitors in dermatology. Dermatol Online J. 2021 Nov 15; 27(11). Hong JJ, Hadeler EK, Mosca ML, Brownstone ND, Bhutani T, Liao WJ. PMID: 35130397.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    62. Innovations in translational research in dermatology: minimally invasive methods for biosample acquisition. Dermatol Online J. 2021 Oct 15; 27(10). Hadeler E, Mosca M, Hong J, Brownstone N, Liao W, Bhutani T. PMID: 35130378.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    63. A cross-sectional study of ethnoracial representation in pediatric plaque psoriasis clinical trials. J Am Acad Dermatol. 2022 02; 86(2):442-444. Mosca M, Hong J, Hadeler E, Hakimi M, Brownstone N, Bhutani T, Liao W. PMID: 34624415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Cultural and biological factors in body dysmorphic disorder in East Asia. Dermatol Online J. 2021 Sep 15; 27(9). Hong J, Hadeler E, Mosca M, Brownstone N, Bhutani T, Koo J. PMID: 34755975.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials. Dermatol Ther (Heidelb). 2021 Oct; 11(5):1497-1520. Mosca M, Hong J, Hadeler E, Hakimi M, Brownstone N, Liao W, Bhutani T. PMID: 34505985; PMCID: PMC8484473.
      View in: PubMed   Mentions: 7  
    66. Perspectives on the Future Development of Mobile Applications for Dermatology Clinical Research. Dermatol Ther (Heidelb). 2021 Oct; 11(5):1451-1456. Hadeler E, Hong J, Mosca M, Hakimi M, Brownstone N, Bhutani T, Liao W. PMID: 34491532; PMCID: PMC8422374.
      View in: PubMed   Mentions: 4  
    67. Atypical Presentation of Pityriasis Rubra Pilaris: Challenges in Diagnosis and Management. Cutis. 2021 Sep; 108(3):E33-E35. Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. PMID: 34826291.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Racial disparities in clinical trials of biologic treatments for psoriatic arthritis. J Am Acad Dermatol. 2022 10; 87(4):910-912. Shwe S, Nguyen C, Bhutani T. PMID: 34464628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. Dupilumab-Induced Facial Flushing After Alcohol Consumption. Cutis. 2021 Aug; 108(2):106-107. Brownstone ND, Reddy V, Thibodeaux Q, Myers B, Chan S, Liao W, Bhutani T. PMID: 34735321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. Seeing the Treatment of Psoriasis in a New Light: A Novel Medical Device Utilizing Localized Coal Tar and Narrowband UVB for Targeted Treatment of Plaque Psoriasis. J Drugs Dermatol. 2021 Jun 01; 20(6):701-702. Brownstone ND, Bridges A, Bhutani T, Anderson E, Sugarman J. PMID: 34076391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Nail Psoriasis: A Review of Effective Therapies and Recommendations for Management. Dermatol Ther (Heidelb). 2021 Jun; 11(3):799-831. Hadeler E, Mosca M, Hong J, Brownstone N, Bhutani T, Liao W. PMID: 33978917; PMCID: PMC8163925.
      View in: PubMed   Mentions: 13  
    72. Genital and Inverse/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management. Dermatol Ther (Heidelb). 2021 Jun; 11(3):833-844. Hong JJ, Mosca ML, Hadeler EK, Brownstone ND, Bhutani T, Liao WJ. PMID: 33914293; PMCID: PMC8163914.
      View in: PubMed   Mentions: 17  
    73. Scalp Psoriasis: A Literature Review of Effective Therapies and Updated Recommendations for Practical Management. Dermatol Ther (Heidelb). 2021 Jun; 11(3):769-797. Mosca M, Hong J, Hadeler E, Brownstone N, Bhutani T, Liao W. PMID: 33893995; PMCID: PMC8163911.
      View in: PubMed   Mentions: 21  
    74. Biologic Treatments of Psoriasis: An Update for the Clinician. Biologics. 2021; 15:39-51. Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J. PMID: 33623366; PMCID: PMC7896737.
      View in: PubMed   Mentions: 63  
    75. A common treatment for a rare condition: Narrowband-Ultraviolet B (NB-UVB) phototherapy for the treatment of a recalcitrant acquired port wine stain. Photodermatol Photoimmunol Photomed. 2021 07; 37(4):293-295. Brownstone N, Bhutani T. PMID: 33377191.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Prescribing Isotretinoin for Transgender Patients: A Call to Action and Recommendations. J Drugs Dermatol. 2021 01 01; 20(1):106-108. Sanchez DP, Brownstone N, Thibodeaux Q, Reddy V, Myers B, Chan S, Bhutani T. PMID: 33400408.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer. J Allergy Clin Immunol. 2021 06; 147(6):2370-2380. Liu J, Chang HW, Huang ZM, Nakamura M, Sekhon S, Ahn R, Munoz-Sandoval P, Bhattarai S, Beck KM, Sanchez IM, Yang E, Pauli M, Arron ST, Fung-Leung WP, Munoz E, Liu X, Bhutani T, North J, Fourie AM, Rosenblum MD, Liao W. PMID: 33309739; PMCID: PMC9179181.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    78. Therapies for Psoriasis: Clinical and Economic Comparisons. J Drugs Dermatol. 2020 Nov 01; 19(11):1101-1108. Marchetti A, Bhutani T, Lockshin B, Siegel DM, Behringer F. PMID: 33196750.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    79. Sleep, Immunological Memory, and Inflammatory Skin Disease. Dermatology. 2021; 237(6):1035-1038. Myers B, Reddy V, Chan S, Thibodeaux Q, Brownstone N, Bhutani T. PMID: 32966973.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults. Clin Cosmet Investig Dermatol. 2020; 13:391-398. Reddy V, Myers B, Yang EJ, Bhutani T. PMID: 32606876; PMCID: PMC7295208.
      View in: PubMed   Mentions:
    81. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Dermatol Ther (Heidelb). 2020 Aug; 10(4):881-885. Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W. PMID: 32468230; PMCID: PMC7255969.
      View in: PubMed   Mentions: 9  
    82. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2019 12; 33(6):101494. Myers B, Brownstone N, Reddy V, Chan S, Thibodeaux Q, Truong A, Bhutani T, Chang HW, Liao W. PMID: 32360228.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    83. Lymphomatoid papulosis successfully managed with excimer laser maintenance therapy. JAAD Case Rep. 2020 Jun; 6(6):495-497. Reddy V, Thibodeaux Q, Bhutani T, Sugarman JL. PMID: 32490107; PMCID: PMC7256238.
      View in: PubMed   Mentions:
    84. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times. Dermatol Ther (Heidelb). 2020 Jun; 10(3):339-349. Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W. PMID: 32300516; PMCID: PMC7160052.
      View in: PubMed   Mentions: 22  
    85. Treatment of Plaque Psoriasis With an Excimer Laser Utilizing an Optimal Therapeutic UVB Dose Protocol. J Drugs Dermatol. 2020 Apr 01; 19(4):49-354. Thibodeaux Q, Beck K, Lockshin BN, Bhatia N, Levin E, Koo J, Bhutani T. PMID: 32272510.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician's Experience. Dermatol Ther (Heidelb). 2020 Jun; 10(3):329-338. Reddy V, Thomas S, Thibodeaux Q, Myers B, Bhutani T, Liao W. PMID: 32193841; PMCID: PMC7211769.
      View in: PubMed   Mentions: 1  
    87. Evaluation of a Genetic Risk Score for Diagnosis of Psoriatic Arthritis. J Psoriasis Psoriatic Arthritis. 2020 Apr; 5(2):61-67. Smith MP, Ly K, Thibodeaux Q, Beck K, Yang E, Sanchez I, Nititham J, Bhutani T, Liao W. PMID: 32462110; PMCID: PMC7252226.
      View in: PubMed   Mentions: 4  
    88. Implementation of an Ultraviolet Phototherapy Service at a National Referral Hospital in Western Kenya: Reflections on Challenges and Lessons Learned. Dermatol Ther (Heidelb). 2020 Feb; 10(1):107-117. Ly K, Chang AY, Kiprono SK, Jose M, Smith MP, Beck K, Sekhon S, Muraguri I, Mungai M, Coates SJ, Thibodeaux Q, Hulse S, Gualberto M, Jeon C, Nakamura M, Bhutani T, Maurer T, Liao W. PMID: 31734938; PMCID: PMC6994574.
      View in: PubMed   Mentions: 1  
    89. Progressive Hyperpigmented Plaques: Answer. Am J Dermatopathol. 2019 Nov; 41(11):862-863. Beck KM, North JP, Bhutani T. PMID: 31633553.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    90. Progressive Hyperpigmented Plaques: Challenge. Am J Dermatopathol. 2019 Nov; 41(11):e134-e135. Beck KM, North JP, Bhutani T. PMID: 30045069.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    91. Beyond the Booth: Excimer Laser for Cutaneous Conditions. Dermatol Clin. 2020 Jan; 38(1):157-163. Ly K, Smith MP, Thibodeaux QG, Beck KM, Liao W, Bhutani T. PMID: 31753188.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    92. Anti IL-17 in psoriasis. Expert Rev Clin Immunol. 2019 11; 15(11):1185-1194. Ly K, Smith MP, Thibodeaux Q, Reddy V, Liao W, Bhutani T. PMID: 31603358.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    93. Palmoplantar Pustulosis in Electronic Cigarette Users: A Potential for Concern. Dermatology. 2019; 235(6):525-526. Reddy V, Bhutani T. PMID: 31597149.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Chronic erythema nodosum with koebnerization to plaque psoriasis. Int J Womens Dermatol. 2019 Dec; 5(5):387-388. Smith MP, Ly K, Thibodeaux Q, Bhutani T. PMID: 31909164; PMCID: PMC6938916.
      View in: PubMed   Mentions:
    95. Acrodermatitis continua of Hallopeau: clinical perspectives. Psoriasis (Auckl). 2019; 9:65-72. Smith MP, Ly K, Thibodeaux Q, Bhutani T, Liao W, Beck KM. PMID: 31497529; PMCID: PMC6691962.
      View in: PubMed   Mentions: 19  
    96. Dupilumab for the treatment of severe photodermatitis. JAAD Case Rep. 2019 Jul; 5(7):614-616. Smith MP, Ly K, Thibodeaux Q, Beck K, Berger T, Khodosh R, Liao W, Bhutani T. PMID: 31341939; PMCID: PMC6629719.
      View in: PubMed   Mentions: 3  
    97. Dupilumab in patients with chronic hepatitis B on concomitant entecavir. JAAD Case Rep. 2019 Jul; 5(7):624-626. Ly K, Smith MP, Thibodeaux Q, Beck K, Bhutani T, Liao W. PMID: 31341942; PMCID: PMC6630033.
      View in: PubMed   Mentions: 8  
    98. Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis. Dermatol Ther (Heidelb). 2019 Sep; 9(3):407-420. Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Wu JJ, Yosipovitch G, Bhutani T, Liao W. PMID: 31256388; PMCID: PMC6704205.
      View in: PubMed   Mentions: 13  
    99. Home phototherapy for patients with vitiligo: challenges and solutions. Clin Cosmet Investig Dermatol. 2019; 12:451-459. Smith MP, Ly K, Thibodeaux Q, Bhutani T, Nakamura M. PMID: 31388308; PMCID: PMC6607222.
      View in: PubMed   Mentions: 4  
    100. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis (Auckl). 2019; 9:37-42. Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. PMID: 31417859; PMCID: PMC6592018.
      View in: PubMed   Mentions: 30  
    101. Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis. Drug Des Devel Ther. 2019; 13:1993-2000. Yang EJ, Smith MP, Ly K, Bhutani T. PMID: 31354244; PMCID: PMC6587972.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort. Dermatol Ther (Heidelb). 2019 Sep; 9(3):511-523. Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, Armstrong AW, Boas M, Bridges A, Doris F, Gelfand JM, Lafoy B, Orbai AM, Takeshita J, Truman S, Wan MT, Wu JJ, Siegel MP, Bell SJ, Bhutani T, Liao W. PMID: 31177381; PMCID: PMC6704222.
      View in: PubMed   Mentions: 13  
    103. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019; 15(9):2129-2139. Thibodeaux Q, Smith MP, Ly K, Beck K, Liao W, Bhutani T. PMID: 30785362; PMCID: PMC6773424.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    104. Dupilumab Treatment for Generalized Prurigo Nodularis. JAMA Dermatol. 2019 Jan 01; 155(1):118-120. Beck KM, Yang EJ, Sekhon S, Bhutani T, Liao W. PMID: 30427994.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    105. The impact of pediatric atopic dermatitis on families: A review. Pediatr Dermatol. 2019 Jan; 36(1):66-71. Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. PMID: 30556595.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    106. A20 and ABIN1 Suppression of a Keratinocyte Inflammatory Program with a Shared Single-Cell Expression Signature in Diverse Human Rashes. J Invest Dermatol. 2019 06; 139(6):1264-1273. Harirchian P, Lee J, Hilz S, Sedgewick AJ, Perez White BE, Kesling MJ, Mully T, Golovato J, Gray M, Mauro TM, Purdom E, Kim EA, Sbitany H, Bhutani T, Vaske CJ, Benz SC, Cho RJ, Cheng JB. PMID: 30543901; PMCID: PMC6642632.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    107. Pharmacy costs of systemic medications for hidradenitis suppurativa in the United States. J Dermatolog Treat. 2019 08; 30(5):519-521. Yang EJ, Beck KM, Bhutani T, Feldman SR, Shi VY. PMID: 30256691.
      View in: PubMed   Mentions: 2     Fields:    
    108. Psoriasis risk factors and triggers. Cutis. 2018 Nov; 102(5S):18-20. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. PMID: 30566552.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    109. Recent Developments in Atopic Dermatitis. Pediatrics. 2018 10; 142(4). Yang EJ, Sekhon S, Sanchez IM, Beck KM, Bhutani T. PMID: 30266868.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    110. Review of European registries for psoriasis. J Dermatolog Treat. 2019 May; 30(3):227-236. Amin M, Lee EB, Bhutani T, Wu JJ. PMID: 30051739.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    111. Pharmacy costs of specialty medications for plaque psoriasis in the United States. J Am Acad Dermatol. 2019 Jan; 80(1):274-275. Yang EJ, Beck KM, Sekhon S, Bhutani T. PMID: 29673778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Guselkumab for the treatment of moderate-to-severe plaque psoriasis. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):333-344. Yang EJ, Sanchez IM, Beck K, Sekhon S, Wu JJ, Bhutani T. PMID: 29478344.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    113. Do psoriasis patients engage in vigorous physical activity? Cutis. 2018 Mar; 101(3):198-200. Amin M, Lee EB, Bhutani T, Wu JJ. PMID: 29718018.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    114. Emerging therapies in psoriasis: a systematic review. Cutis. 2018 Mar; 101(3S):5-9. Lee EB, Amin M, Bhutani T, Wu JJ. PMID: 29718027.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    115. Neuromodulation in Inflammatory Skin Disease. Dermatol Ther (Heidelb). 2018 Mar; 8(1):1-4. Yang EJ, Sekhon S, Beck KM, Bhutani T, Koo J. PMID: 29427206; PMCID: PMC5825332.
      View in: PubMed   Mentions: 3  
    116. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies. Cutis. 2018 Jan; 101(1):38;42;56. Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani T. PMID: 29529104.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    117. A systematic review of active comparator controlled clinical trials in patients with moderate-to-severe psoriasis. J Dermatolog Treat. 2018 Aug; 29(5):467-474. No DJ, Amin M, Bhutani T, Wu JJ. PMID: 29103334.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis. Psoriasis (Auckl). 2017; 7:65-72. Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E. PMID: 29387609; PMCID: PMC5774608.
      View in: PubMed   Mentions: 5  
    119. Review of IL-17 inhibitors for psoriasis. J Dermatolog Treat. 2018 Jun; 29(4):347-352. Amin M, Darji K, No DJ, Bhutani T, Wu JJ. PMID: 29058501.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    120. Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities. JAAD Case Rep. 2017 Nov; 3(6):495-497. Jeon C, Nakamura M, Sekhon S, Yan D, Wu JJ, Liao W, Bhutani T. PMID: 29034298; PMCID: PMC5635247.
      View in: PubMed   Mentions: 13  
    121. Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis. Hum Vaccin Immunother. 2017 10 03; 13(10):2247-2259. Jeon C, Sekhon S, Yan D, Afifi L, Nakamura M, Bhutani T. PMID: 28825875; PMCID: PMC5647990.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    122. Review of the mechanism of action of coal tar in psoriasis. J Dermatolog Treat. 2018 May; 29(3):230-232. Sekhon S, Jeon C, Nakamura M, Afifi L, Yan D, Wu JJ, Liao W, Bhutani T. PMID: 28814117.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    123. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. J Am Acad Dermatol. 2017 Oct; 77(4):713-718. Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST. PMID: 28780365.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    124. Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review. Dermatol Ther (Heidelb). 2017 Sep; 7(3):349-364. Jeon C, Yan D, Nakamura M, Sekhon S, Bhutani T, Berger T, Liao W. PMID: 28707054; PMCID: PMC5574743.
      View in: PubMed   Mentions: 40  
    125. Update on the Systemic Risks of Superpotent Topical Steroids. J Drugs Dermatol. 2017 Jul 01; 16(7):643-648. Nakamura M, Abrouk M, Zhu H, Farahnik B, Koo J, Bhutani T. PMID: 28697215.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    126. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017 07; 77(1):177-180. Abrouk M, Farahnik B, Zhu TH, Nakamura M, Singh R, Lee K, Lucking SM, Blossom J, Liao W, Koo J, Bhutani T, Shinkai K, Nguyen T. PMID: 28619562.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    127. Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2017 Sep; 7(3):281-292. Nakamura M, Lee K, Jeon C, Sekhon S, Afifi L, Yan D, Lee K, Bhutani T. PMID: 28639011; PMCID: PMC5574739.
      View in: PubMed   Mentions: 22  
    128. Beyond monotherapy: a systematic review on creative strategies in topical therapy of psoriasis. J Dermatolog Treat. 2017 Dec; 28(8):702-708. Koo K, Jeon C, Bhutani T. PMID: 28481664.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case report. Dermatol Online J. 2017 May 15; 23(5). Farahnik B, Beroukhim K, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J, Liao W. PMID: 28537861.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    130. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017 04 08; 15(1):73. Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. PMID: 28388917; PMCID: PMC5385025.
      View in: PubMed   Mentions: 1239     Fields:    Translation:Humans
    131. Warfarin-Associated Nonuremic Calciphylaxis. JAMA Dermatol. 2017 03 01; 153(3):309-314. Yu WY, Bhutani T, Kornik R, Pincus LB, Mauro T, Rosenblum MD, Fox LP. PMID: 28099971; PMCID: PMC5703198.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    132. Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule. Int J Womens Dermatol. 2017 Mar; 3(1 Suppl):S67-S69. Abrouk M, Beroukhim K, Nakamura M, Zhu TH, Farahnik B, Singh R, Lee K, Koo J, Bhutani T. PMID: 28492043; PMCID: PMC5419054.
      View in: PubMed   Mentions:
    133. Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability. Psoriasis (Auckl). 2016; 6:165-173. Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. PMID: 29387603; PMCID: PMC5683125.
      View in: PubMed   Mentions: 10  
    134. Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study. J Am Acad Dermatol. 2016 Nov; 75(5):1068-1071. Farahnik B, Beroukhim K, Danesh M, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. PMID: 27745637.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    135. Obsessive-compulsive skin disorders: a novel classification based on degree of insight. J Dermatolog Treat. 2017 Jun; 28(4):342-346. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Reichenberg J, Bhutani T, Koo J. PMID: 27658538.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    136. Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review. J Dermatolog Treat. 2017 May; 28(3):237-241. Nakamura M, Lee K, Singh R, Zhu TH, Farahnik B, Abrouk M, Koo J, Bhutani T. PMID: 27571340.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    137. Uremic pruritus treated successfully with the Goeckerman Program. Dermatol Online J. 2016 Aug 15; 22(8). Nakamura M, Koo J, Bhutani T. PMID: 27617950.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. The Patient's Guide to Psoriasis Treatment. Part 1: UVB Phototherapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):307-13. Singh RK, Lee KM, Jose MV, Nakamura M, Ucmak D, Farahnik B, Abrouk M, Zhu TH, Bhutani T, Liao W. PMID: 27474029; PMCID: PMC4972735.
      View in: PubMed   Mentions: 9  
    139. The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):333-9. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Singh RK, Lee KM, Hulse S, Koo J, Bhutani T, Liao W. PMID: 27474032; PMCID: PMC4972738.
      View in: PubMed   Mentions: 2  
    140. The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables. Dermatol Ther (Heidelb). 2016 Sep; 6(3):325-31. Abrouk M, Nakamura M, Zhu TH, Farahnik B, Singh RK, Lee KM, Jose MV, Koo J, Bhutani T, Liao W. PMID: 27474031; PMCID: PMC4972737.
      View in: PubMed   Mentions: 2  
    141. The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):315-24. Farahnik B, Nakamura M, Singh RK, Abrouk M, Zhu TH, Lee KM, Jose MV, DaLovisio R, Koo J, Bhutani T, Liao W. PMID: 27474030; PMCID: PMC4972736.
      View in: PubMed   Mentions: 7  
    142. Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability. Psoriasis (Auckl). 2016; 6:105-111. Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J. PMID: 29387597; PMCID: PMC5683119.
      View in: PubMed   Mentions: 7  
    143. Recent advances in phototherapy for psoriasis. F1000Res. 2016; 5. Nakamura M, Farahnik B, Bhutani T. PMID: 27499849; PMCID: PMC4946393.
      View in: PubMed   Mentions: 5     Fields:    
    144. Narrowband UVB-induced iatrogenic polymorphous light eruption: a case and suggestions to overcome this rare complication. Dermatol Online J. 2016 Jun 15; 22(6). Nakamura M, Bhutani T, Koo JY. PMID: 27617609.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    145. The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury. Am J Clin Dermatol. 2016 Jun; 17(3):257-63. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Lee K, Singh R, Gevorgyan A, Koo J, Bhutani T. PMID: 26935938.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    146. Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2016 Jun; 6(2):111-24. Farahnik B, Beroukhim K, Abrouk M, Nakamura M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. PMID: 27221323; PMCID: PMC4906115.
      View in: PubMed   Mentions: 35  
    147. Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule. Int J Womens Dermatol. 2016 Jun; 2(2):62-64. Abrouk M, Beroukhim K, Nakamura M, Zhu TH, Farahnik B, Singh R, Brodsky M, Lee K, Koo J, Bhutani T. PMID: 28492009; PMCID: PMC5412117.
      View in: PubMed   Mentions: 2  
    148. Anti-IL-17 Agents for Psoriasis: A Review of Phase III Data. J Drugs Dermatol. 2016 Mar; 15(3):311-6. Farahnik B, Beroukhim K, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. PMID: 26954316.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    149. Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2016 Mar; 6(1):25-37. Farahnik B, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J. PMID: 26910853; PMCID: PMC4799032.
      View in: PubMed   Mentions: 27  
    150. A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol. 2013 Aug; 69(2):e79-88. Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J. PMID: 23207011.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    151. Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study. J Dermatolog Treat. 2013 Oct; 24(5):348-50. Bhutani T, Kamangar F, Zitelli K, Chiang C, Gattu S, Nguyen T, Becker E, Koo J. PMID: 22506829.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    152. A review of the chemopreventative effects of oral retinoids for internal neoplasms. J Drugs Dermatol. 2011 Nov; 10(11):1292-8. Bhutani T, Koo J. PMID: 22052311.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    153. Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis. J Drugs Dermatol. 2011 Aug; 10(8):831-4. Bhutani T, Zitelli KB, Koo J. PMID: 21818503.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    154. Efficacy of clobetasol spray: factors beyond patient compliance. J Dermatolog Treat. 2012 Feb; 23(1):11-5. Bhutani T, Koo J, Maibach HI. PMID: 21254848.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    155. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series. J Dermatolog Treat. 2011 Apr; 22(2):75-8. Bhutani T, Koo J. PMID: 20524874.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Tina's Networks
    Concepts (299)
    Derived automatically from this person's publications.
    _
    Co-Authors (46)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _